Great Europe-Patent News for NSPR (01.05.2017):
https://register.epo.org/application?number=EP07827415
NSPR is still one of the Cheapest NYSE stocks based on the New BV & CV! The 10-Q confirms its 100% Debt-Free financial status which is the most important fundamental for a big board stock !
InspireMD was founded in 2005 with the purpose of creating a technology that could solve the problem of embolization in high risk vascular procedures. The company has grown to include a portfolio of embolic protection systems, which it both manufactures and commercializes.
Today, InspireMD is a global company headquartered in Boston, MA. InspireMD seeks to utilize its proprietary MicroNetTM technology to make its products the industry standard for embolic protection by providing a superior solution to the key clinical issues of vascular procedures.
Our Technology
MicroNetTM
The MicroNet is a bio-stable mesh woven from a single strand of 20 μm Polyethylene Terephthalate (PET). The MicroNet is designed to trap and seal thrombus and plaque against the vessel wall, preventing embolization.
MicroNetTM key features:
- PET is a bio-stable synthetic fiber widely used in a variety of industries.
Attached and secured to the proximal and the distal crowns of the stent.
Does not alter the procedure as it expands with the stent.
Pore size is typically between 150 – 180 µm.
CGuard™
need for tapered version
Carotid Embolic Prevention System
The CGuardTM Embolic Prevention System (EPS) is designed to prevent peri-procedural and late embolization by trapping potential emboli against the arterial wall while maintaining excellent perfusion to the external carotid artery and branch vessels.
Product Details:
MicroNet material: Polyethylene Terephthalate (PET)
- Easy to use RX (Rapid Exchange) delivery system
MGuard™
Improving Clinical Outcomes For STEMI Patients
The MGuardTM Embolic Protection System (EPS), integrated with MicroNetTM (see Our Technology), is designed to trap and seal thrombus and ruptured plaque, prevent distal embolization and optimize flow.
While offering performance that is superior to standard STEMI therapy, MGuard requires no change in current physician practice – an important factor in time-critical settings.
Product Details:
- MGuard material: Stainless Steel 316
- MicroNet material: Polyethylene Terephthalate (PET)
MGuard Prime™
Improving Clinical Outcomes For STEMI Patients
The MGuard PrimeTM Embolic Protection System (EPS), integrated with MicroNetTM (see Our Technology), is designed to trap and seal thrombus and ruptured plaque, prevent distal embolization, and optimize flow, while ensuring excellent deliverabililty.
While offering performance that is superior to standard STEMI therapy, MGuard Prime requires no change in current physician practice – an important factor in time-critical settings.
Product Details:
- MGuard Prime material: Cobalt Chromium (CoCr) L605
MicroNet material: Polyethylene Terephthalate (PET)
- Superior flexibility and excellent deliverability
http://www.inspiremd.com/en/products/the-technology/ 2017 News
Thursday23March 2017
BOSTON, MA—March 23, 2017 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS), neurovascular devices and thrombus management technologies, today announced that its…
Wednesday22March 2017
Tel Aviv—March 22, 2017 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices, today announced that…
Tuesday21March 2017
BOSTON, MA—March 21, 2017 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices, today announced it…
Monday20March 2017
Tel Aviv—March 20, 2017 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices, today announced it…
Wednesday15March 2017
Announces Agreements with Leading Distributors in the Baltic States BOSTON, MA—March 15, 2017 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS)…
Tuesday14March 2017
BOSTON, MA – March 14, 2017 – InspireMD, Inc. (NYSE MKT: NSPR) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices,…
Thursday09March 2017
BOSTON, MA – March 9, 2017 – InspireMD, Inc. (NYSE MKT: NSPR) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices,…
Thursday16February 2017
Transition from Exclusive Distribution Partner to Local Distributors and Internal Sales Strategy Validated by Strong Revenue Growth in Select Markets BOSTON, MA—February 16, 2017 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS)…
Tuesday24January 2017
PD Dr. Andrej Schmidt to perform live case transmission of carotid stent surgery utilizing CGuard™ BOSTON, MA– January 24, 2016 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS) (“InspireMD” or the “Company”), a…
Contact Us
Thank you for your interest in InspireMD, please let us know how we can help you. You can contact us at info@inspiremd.com or 1-888-776-6804.
Executives
James J. BarryPresident & Chief Executive Officer
Dr. Barry has over 20 years of experience in the medical device industry. Prior to joining InspireMD, he was the President and CEO of Arsenal Medical, a life sciences company…
Mr. Shore has over 25 years of experience in financial management in the United States, Europe and Israel. He has served in various senior financial and general management roles at…
Agustin GagoExecutive Vice President and Chief Commercial Officer
Mr. Gago has over 25 years of experience in building profitable international commercial, sales and marketing organizations. Prior to joining InspireMD, he was the founder and principal of Dash International…
Mr. Spector has more than 25 years of experience in research, development and engineering, serving as the lead on a range of product lines and systems in the healthcare space….
Mrs. Shachar has over 12 years of experience in quality, regulatory and clinical execution, serving in executive roles in small and large medical companies. Prior to joining InspireMD, she…
Website: http://www.inspiremd.com/en/
